(19)
(11) EP 2 931 042 A1

(12)

(43) Date of publication:
21.10.2015 Bulletin 2015/43

(21) Application number: 13863251.8

(22) Date of filing: 13.12.2013
(51) International Patent Classification (IPC): 
A01N 43/04(2006.01)
A61K 31/70(2006.01)
(86) International application number:
PCT/US2013/075002
(87) International publication number:
WO 2014/093815 (19.06.2014 Gazette 2014/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 13.12.2012 US 201261737003 P

(71) Applicant: CytRx Corporation
Los Angeles, CA 90049 (US)

(72) Inventors:
  • GEYER, Scott
    Oakland, CA 94611 (US)
  • LEVITT, Daniel
    San Francisco, CA 94118 (US)
  • NODGAARD, Carrie
    Los Angeles, CA 90049 (US)
  • TRAPPLER, Edward, H.
    Langhorne, PA 18974 (US)

(74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB 
Siebertstrasse 3
81675 München
81675 München (DE)

   


(54) ANTHRACYCLINE FORMULATIONS